Mostrar el registro sencillo del ítem

dc.contributor.authorSeijo Bestilleiro, Rocío 
dc.contributor.authorSeoane Pillado, María Teresa 
dc.contributor.authorPertega Diaz, Sonia 
dc.contributor.authorGonzález Martín, Cristina
dc.contributor.authorValdés Cañedo, Francisco
dc.contributor.authorBalboa Barreiro, Vanesa
dc.contributor.authorFernández Rivera, Constantino 
dc.contributor.authorAlonso Hernández, Ángel
dc.contributor.authorCao Vilarino, Mercedes 
dc.contributor.authorGil-Guillen, Vicente
dc.contributor.authorGarcía Rodríguez, María Teresa
dc.date.accessioned2022-03-08T08:51:12Z
dc.date.available2022-03-08T08:51:12Z
dc.date.issued2020
dc.identifier.issn1449-1907
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/33162795es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/16220
dc.description.abstractBackground: measure the efficacy of exhaled carbon monoxide (CO) measurement plus brief advisory sessions to reduce smoking exposure and smoking behaviour in kidney transplant recipients. Methods: Randomized, controlled, open-label clinical trial at a Spanish hospital.Smoking kidney transplant recipients giving their consent to participate were randomized to control (brief advice, n=63) or intervention group (brief advisory session plus measuring exhaled CO, n=59). Measurements: Sociodemographic characteristics, cardiovascular risk factors, treatment, rejection episodes, infections, self-reported smoking, drug use, level of dependence and motivation to stop smoking (Fagerstrom's and Richmond's test) and stage of change (Prochaska and DiClemente's Stages). Efficacy was assessed at 3, 6, 9 and 12 months as: cotinine test, CO levels in exhaled air, nicotine dependence, motivational stages of change, motivation to stop smoking, pattern of tobacco use and smoking cessation rates. Logistic regression models were computed. Results: At 12 months of follow-up, differences were found in exhaled CO between the intervention and control group(6.1+/-6.8vs.10.2+/-9.7ppm;p=0.028). Carboxyhemoglobin levels were lower in the intervention group as well as the positive cotinine test (1.2+/-1.2%vs.2.0+/-2.4%;p=0.039),(53.4%vs.74.2%). At 12 months, intervention reduces the probability of a positive urine test by 28%. Conclusions: Co-oximetry is a clinically relevant intervention for reduction of tobacco exposure in kidney transplant recipients.en
dc.rightsAtribución-NoComercial 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subject.meshMiddle Aged*
dc.subject.meshCarbon Monoxide*
dc.subject.meshOximetry*
dc.subject.meshFollow-Up Studies*
dc.subject.meshPatient Education as Topic*
dc.subject.meshSelf Report*
dc.subject.meshGraft Rejection*
dc.subject.meshSmoking*
dc.subject.meshHumans*
dc.subject.meshTreatment Outcome*
dc.subject.meshMotivation*
dc.subject.meshSmoking Cessation*
dc.subject.meshControlled Clinical Trial*
dc.subject.meshCotinine*
dc.subject.meshKidney Transplantation*
dc.titleRandomized clinical trial to determine the effectiveness of CO-oximetry and anti-smoking brief advice in a cohort of kidney transplant patients who smokeen
dc.typeJournal Articlees
dc.authorsophosSeijo-Bestilleiro, Rocio;Seoane-Pillado, Teresa;Pertega-Diaz, Sonia;González-Martín, Cristina;Valdes-Cañedo, Francisco;Balboa-Barreiro, Vanesa;Fernandez-Rivera, Constantino;Alonso-Hernandez, Angel;Cao-Vilariño, Mercedes;Gil-Guillen, Vicente;Garcia-Rodriguez, Mª Teresa
dc.identifier.doi10.7150/ijms.49401
dc.identifier.pmid33162795
dc.identifier.sophos35922
dc.issue.number17es
dc.journal.titleInternational Journal of Medical Scienceses
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario de A Coruña::Nefroloxíaes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::Instituto de Investigación Biomédica da Coruña (INIBIC)es
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario de A Coruña::Epidemioloxíaes
dc.relation.publisherversionhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645331/pdf/ijmsv17p2673.pdfes
dc.rights.accessRightsopenAccess
dc.subject.decsresultado del tratamiento*
dc.subject.decstrasplante de riñón*
dc.subject.decsensayo clínico controlado*
dc.subject.decseducación de pacientes como asunto*
dc.subject.decsautoinforme*
dc.subject.decsestudios de seguimiento*
dc.subject.decsmediana edad*
dc.subject.decsadulto*
dc.subject.decsrechazo del injerto*
dc.subject.decsmotivación*
dc.subject.decscotinina*
dc.subject.decscese del hábito de fumar*
dc.subject.decsmonóxido de carbono*
dc.subject.decshumanos*
dc.subject.decshábito de fumar*
dc.subject.decsoximetría*
dc.subject.keywordCHUACes
dc.subject.keywordINIBICes
dc.typefidesArtículo Originales
dc.typesophosArtículo Originales
dc.volume.number17es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial 4.0 Internacional